Coleman Mark
SEC insider (Form 3/4/5 filer). CIK 0001658379. Director at Axsome Therapeutics, Inc. (AXSM). 20 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in NEW YORK, NY.
Companies Coleman Mark has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Director
Coleman Mark
CIK: 0001658379
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jun 10, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect643 shares at avg. $249.00$160K - Jun 8, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect1.4K shares- - Jun 5, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
1.7K shares- - Jun 2, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect5.5K shares at avg. $223.39$1.2M - Jun 1, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect6K shares at avg. $230.30$1.4M - May 29, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect6K shares at avg. $233.46$1.4M - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect25K shares at avg. $161.11$4.0M - Feb 23, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect6.3K shares at avg. $4.95$31K - Feb 20, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect12.5K shares at avg. $4.95$62K - Feb 10, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect5.2K shares at avg. $8.02$42K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 643 | $249.00 | $160,107 | Direct |
| Jun 8, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 1,429 | - | $0 | Direct |
| Jun 5, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 1,721 | - | - | Direct |
| Jun 2, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 5,537 | $223.39 | $1,236,910 | Direct |
| Jun 1, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 6,000 | $230.30 | $1,381,800 | Direct |
| May 29, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 6,000 | $233.46 | $1,400,760 | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 25,000 | $161.11 | $4,027,750 | Direct |
| Feb 23, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 6,250 | $4.95 | $30,938 | Direct |
| Feb 20, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 12,485 | $4.95 | $61,801 | Direct |
| Feb 10, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 5,193 | $8.02 | $41,648 | Direct |
1-10 of 20 transactions